SELVAS Healthcare, Inc. (KOSDAQ:208370)
South Korea
· Delayed Price · Currency is KRW 4,360.00
+35.00 (0.81%)
At close: Mar 26, 2025, 3:30 PM KST
SELVAS Healthcare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 31,702 | 29,813 | 27,686 | 29,089 | 21,152 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | -0 | - | Upgrade
|
| Revenue | 31,702 | 29,813 | 27,686 | 29,089 | 21,152 | Upgrade
|
| Revenue Growth (YoY) | 6.34% | 7.68% | -4.83% | 37.52% | -5.36% | Upgrade
|
| Cost of Revenue | 15,141 | 14,163 | 13,701 | 15,236 | 11,490 | Upgrade
|
| Gross Profit | 16,561 | 15,650 | 13,985 | 13,853 | 9,662 | Upgrade
|
| Selling, General & Admin | 9,634 | 8,572 | 8,009 | 7,358 | 5,796 | Upgrade
|
| Research & Development | 3,161 | 3,113 | 2,798 | 2,335 | 1,875 | Upgrade
|
| Other Operating Expenses | - | - | 69.31 | 52.91 | 52.66 | Upgrade
|
| Operating Expenses | 13,287 | 12,301 | 11,498 | 10,437 | 8,144 | Upgrade
|
| Operating Income | 3,275 | 3,349 | 2,486 | 3,416 | 1,518 | Upgrade
|
| Interest Expense | -236.17 | -227.23 | -511.12 | -639.5 | -697.85 | Upgrade
|
| Interest & Investment Income | 771.93 | 466.57 | 129.93 | 95.62 | 102.07 | Upgrade
|
| Earnings From Equity Investments | -200.83 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 1,189 | 59.29 | 372.57 | 311.19 | -136.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 125.04 | 122.67 | 920.3 | 57.9 | 590.67 | Upgrade
|
| EBT Excluding Unusual Items | 4,924 | 3,770 | 3,398 | 3,241 | 1,377 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1,638 | 233.99 | 19.33 | 118.05 | 5.83 | Upgrade
|
| Gain (Loss) on Sale of Assets | 13.26 | -146.44 | 3.61 | 5.08 | 11.79 | Upgrade
|
| Asset Writedown | - | - | -206.46 | -827.25 | -649.26 | Upgrade
|
| Other Unusual Items | - | - | -362.69 | - | - | Upgrade
|
| Pretax Income | 3,299 | 3,858 | 2,852 | 2,537 | 745.13 | Upgrade
|
| Income Tax Expense | 146.94 | -1,312 | 39.05 | 65.18 | -13.57 | Upgrade
|
| Net Income | 3,152 | 5,170 | 2,813 | 2,472 | 758.7 | Upgrade
|
| Net Income to Common | 3,152 | 5,170 | 2,813 | 2,472 | 758.7 | Upgrade
|
| Net Income Growth | -39.03% | 83.79% | 13.81% | 225.77% | - | Upgrade
|
| Shares Outstanding (Basic) | 26 | 24 | 22 | 22 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 24 | 24 | 22 | 22 | Upgrade
|
| Shares Change (YoY) | 6.94% | 2.23% | 9.11% | 0.02% | 55.29% | Upgrade
|
| EPS (Basic) | 123.00 | 215.00 | 126.14 | 114.12 | 35.04 | Upgrade
|
| EPS (Diluted) | 122.00 | 214.00 | 94.38 | 114.00 | 35.00 | Upgrade
|
| EPS Growth | -42.99% | 126.75% | -17.21% | 225.71% | - | Upgrade
|
| Free Cash Flow | 3,783 | 3,112 | -301.51 | 2,557 | 4,089 | Upgrade
|
| Free Cash Flow Per Share | 146.44 | 128.82 | -12.76 | 118.08 | 188.84 | Upgrade
|
| Gross Margin | 52.24% | 52.50% | 50.51% | 47.62% | 45.68% | Upgrade
|
| Operating Margin | 10.33% | 11.23% | 8.98% | 11.74% | 7.18% | Upgrade
|
| Profit Margin | 9.94% | 17.34% | 10.16% | 8.50% | 3.59% | Upgrade
|
| Free Cash Flow Margin | 11.93% | 10.44% | -1.09% | 8.79% | 19.33% | Upgrade
|
| EBITDA | 4,323 | 4,360 | 3,585 | 4,998 | 3,672 | Upgrade
|
| EBITDA Margin | 13.64% | 14.62% | 12.95% | 17.18% | 17.36% | Upgrade
|
| D&A For EBITDA | 1,048 | 1,011 | 1,099 | 1,582 | 2,154 | Upgrade
|
| EBIT | 3,275 | 3,349 | 2,486 | 3,416 | 1,518 | Upgrade
|
| EBIT Margin | 10.33% | 11.23% | 8.98% | 11.74% | 7.18% | Upgrade
|
| Effective Tax Rate | 4.45% | - | 1.37% | 2.57% | - | Upgrade
|
| Advertising Expenses | 390.55 | 283.96 | 361.05 | 89.95 | 72.61 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.